Kwok-Leung Ong1, Jingzhong Ding2, Robyn L McClelland3, Bernard M Y Cheung4, Michael H Criqui5, Philip J Barter6, Kerry-Anne Rye6, Matthew A Allison5. 1. Centre for Vascular Research, University of New South Wales, Sydney, NSW 2025, Australia. Electronic address: oklws@yahoo.com.hk. 2. Sticht Center on Aging, Wake Forest University School of Medicine, Winston-Salem, NC, United States. 3. Department of Biostatistics, University of Washington, Seattle, WA, United States. 4. Department of Medicine, University of Hong Kong, Hong Kong, China. 5. Department of Family and Preventive Medicine, University of California San Diego, La Jolla, CA, United States. 6. Centre for Vascular Research, University of New South Wales, Sydney, NSW 2025, Australia; Faculty of Medicine, University of Sydney, Sydney, NSW, Australia.
Abstract
OBJECTIVE: Pericardial fat and lipoprotein abnormalities contribute to increased risk of cardiovascular disease (CVD). We investigated the relationship between pericardial fat volume and lipoprotein distribution, and whether the association of pericardial fat volume with subclinical atherosclerosis and incident CVD events differs according to lipoprotein distribution. METHODS: We analyzed data from 5407 participants from the Multi-Ethnic Study of Atherosclerosis who had measurements of pericardial fat volume, lipoprotein distribution, carotid intima-media thickness (IMT), and coronary artery calcium (CAC). All participants were free of clinically apparent CVD at baseline. Incident CVD was defined as any adjudicated CVD event. RESULTS: After adjusting for demographic factors, traditional risk factors, and biomarkers of inflammation and hemostasis, a larger pericardial fat volume was associated with higher large VLDL particle (VLDL-P) concentration and small HDL particle (HDL-P) concentration, and smaller HDL-P size (regression coefficients = 0.585 nmol/L, 0.366 μmol/L, and -0.025 nm per SD increase in pericardial fat volume respectively, all P < 0.05). The association of pericardial fat volume with large VLDL-P concentration and HDL-P size, but not small HDL-P concentration, remained significant after further adjusting for each other as well as LDL cholesterol, HDL cholesterol, and triglycerides. The relationship of pericardial fat volume with incident CVD events, carotid IMT, and prevalence and severity of CAC did not differ by quartiles of large VLDL-P concentration, small HDL-P concentration, or HDL-P size (P for interaction>0.05). CONCLUSION: Pericardial fat is associated with atherogenic lipoprotein abnormalities. However, its relationship with subclinical atherosclerosis and incident CVD events does not differ according to lipoprotein distribution.
OBJECTIVE: Pericardial fat and lipoprotein abnormalities contribute to increased risk of cardiovascular disease (CVD). We investigated the relationship between pericardial fat volume and lipoprotein distribution, and whether the association of pericardial fat volume with subclinical atherosclerosis and incident CVD events differs according to lipoprotein distribution. METHODS: We analyzed data from 5407 participants from the Multi-Ethnic Study of Atherosclerosis who had measurements of pericardial fat volume, lipoprotein distribution, carotid intima-media thickness (IMT), and coronary artery calcium (CAC). All participants were free of clinically apparent CVD at baseline. Incident CVD was defined as any adjudicated CVD event. RESULTS: After adjusting for demographic factors, traditional risk factors, and biomarkers of inflammation and hemostasis, a larger pericardial fat volume was associated with higher large VLDL particle (VLDL-P) concentration and small HDL particle (HDL-P) concentration, and smaller HDL-P size (regression coefficients = 0.585 nmol/L, 0.366 μmol/L, and -0.025 nm per SD increase in pericardial fat volume respectively, all P < 0.05). The association of pericardial fat volume with large VLDL-P concentration and HDL-P size, but not small HDL-P concentration, remained significant after further adjusting for each other as well as LDL cholesterol, HDL cholesterol, and triglycerides. The relationship of pericardial fat volume with incident CVD events, carotid IMT, and prevalence and severity of CAC did not differ by quartiles of large VLDL-P concentration, small HDL-P concentration, or HDL-P size (P for interaction>0.05). CONCLUSION: Pericardial fat is associated with atherogenic lipoprotein abnormalities. However, its relationship with subclinical atherosclerosis and incident CVD events does not differ according to lipoprotein distribution.
Authors: Victor Y Cheng; Damini Dey; Balaji Tamarappoo; Ryo Nakazato; Heidi Gransar; Romalisa Miranda-Peats; Amit Ramesh; Nathan D Wong; Leslee J Shaw; Piotr J Slomka; Daniel S Berman Journal: JACC Cardiovasc Imaging Date: 2010-04
Authors: Samia Mora; Moyses Szklo; James D Otvos; Philip Greenland; Bruce M Psaty; David C Goff; Daniel H O'Leary; Mohammed F Saad; Michael Y Tsai; A Richey Sharrett Journal: Atherosclerosis Date: 2007-05 Impact factor: 5.162
Authors: Alain G Bertoni; Melicia C Whitt-Glover; Hyoju Chung; Katherine Y Le; R Graham Barr; Mahadevappa Mahesh; Nancy S Jenny; Gregory L Burke; David R Jacobs Journal: Am J Epidemiol Date: 2008-12-15 Impact factor: 4.897
Authors: Jingzhong Ding; Fang-Chi Hsu; Tamara B Harris; Yongmei Liu; Stephen B Kritchevsky; Moyses Szklo; Pamela Ouyang; Mark A Espeland; Kurt K Lohman; Michael H Criqui; Matthew Allison; David A Bluemke; J Jeffrey Carr Journal: Am J Clin Nutr Date: 2009-07-01 Impact factor: 7.045
Authors: Amir A Mahabadi; Joseph M Massaro; Guido A Rosito; Daniel Levy; Joanne M Murabito; Philip A Wolf; Christopher J O'Donnell; Caroline S Fox; Udo Hoffmann Journal: Eur Heart J Date: 2009-01-09 Impact factor: 29.983
Authors: Samia Mora; James D Otvos; Nader Rifai; Robert S Rosenson; Julie E Buring; Paul M Ridker Journal: Circulation Date: 2009-02-09 Impact factor: 29.690
Authors: Matthew A Allison; Matthew J Budoff; Khurram Nasir; Nathan D Wong; Robert Detrano; Richard Kronmal; Junichiro Takasu; Michael H Criqui Journal: Am J Cardiol Date: 2009-09-15 Impact factor: 2.778
Authors: Ian H de Boer; Brad C Astor; Holly Kramer; Walter Palmas; Kyle Rudser; Stephen L Seliger; Michael G Shlipak; David S Siscovick; Michael Y Tsai; Bryan Kestenbaum Journal: Atherosclerosis Date: 2007-08-06 Impact factor: 5.162
Authors: R V Shah; V L Murthy; M A Allison; J Ding; M Budoff; A C Frazier-Wood; J A C Lima; L Steffen; D Siscovick; K L Tucker; P Ouyang; S A Abbasi; K Danielson; M Jerosch-Herold; D Mozaffarian Journal: Nutr Metab Cardiovasc Dis Date: 2015-12-29 Impact factor: 4.222
Authors: Tiffany M Powell-Wiley; Paul Poirier; Lora E Burke; Jean-Pierre Després; Penny Gordon-Larsen; Carl J Lavie; Scott A Lear; Chiadi E Ndumele; Ian J Neeland; Prashanthan Sanders; Marie-Pierre St-Onge Journal: Circulation Date: 2021-04-22 Impact factor: 29.690
Authors: Jeff Min; Mary E Putt; Wei Yang; Alain G Bertoni; Jingzhong Ding; Joao A C Lima; Matthew A Allison; R Graham Barr; Nadine Al-Naamani; Ravi B Patel; Lauren Beussink-Nelson; Steven M Kawut; Sanjiv J Shah; Benjamin H Freed Journal: J Am Soc Echocardiogr Date: 2022-01-19 Impact factor: 7.722